-
Oculus Innovative Sciences Gains 23%, Company Receives European Approval To Market Sinudox
Wednesday, April 13, 2016 - 9:13am | 287Read More...Shares of Oculus Innovative Sciences, Inc. (NASDAQ: OCLS), a nano-cap specialty device and pharmaceutical company that focuses on the treatment of dermatological conditions, were trading higher by more than 23 percent early Wednesday morning. Oculus announced that it has received European approval...

